Practice Overview

Revenue surged 12.2% MoM to $438k in February, driven by increased patient volume (+8.4%) and improved charge capture. Total payments reached $312k (+12.8%) with NCR at 94.2% — well above the 89.5% derm industry average. Days in A/R crept to 32 days due to UHC processing delays. Denial rate at 5.2% needs attention — CO-16 documentation issues are the primary driver.